Dr. David HE
Dr. David HE, Chief Technology Officer and Executive Vice President
Dr. He brings to IASO bio more than 30 years of experience with an excellent track record of successfully developing novel oncology therapies and biomedical research. He has extensive experience in the process development and GMP production of cellular immunotherapies and biological products. Previously, Dr. He held leadership positions in innovative biotech or global pharmaceutical company such as Clover Bio, Legend Bio, and Boehringer Ingelheim in China and the United States. As a key decision maker, he led technical operations teams in successfully achieving GMP compliant manufacturing and BLA filing in accordance with FDA/ NMPA/ EMA/ ICH guidelines. David holds a Ph.D. in Pathogenic Biology from Sun Yat-sen University, and completed postdoctoral research in immunology at the University of Alabama at Birmingham.